Skip to content

Cytokine adsorption by CytoSorb in critically-ill COVID-19 patients

Combination of ECMO and CytoSorb hemoadsorption in COVID-19 patients and beyond
Chair: Roberto Lorusso, Maastricht/The Netherlands

  • Agenda Rationale for the use of CytoSorb in ECMO patients
    L. Christian Napp, Hannover/Germany
  • Cytokine adsorption in severe COVID-19 pneumonia requiring ECMO – the CYCOV study
    Alexander Supady, Freiburg/Germany
  • First clinical experiences in the USA
    Nader Moazami, New York/USA
  • Reduction of hyperinflammation, septic shock and MOF – we can do it better
    Ali Akil, Ibbenbueren/Germany
Play Video

Share

|

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

Cytokine adsorption by CytoSorb in critically-ill COVID-19 patients

Play Video

Share

|

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

Combination of ECMO and CytoSorb hemoadsorption in COVID-19 patients and beyond
Chair: Roberto Lorusso, Maastricht/The Netherlands

  • Agenda Rationale for the use of CytoSorb in ECMO patients
    L. Christian Napp, Hannover/Germany
  • Cytokine adsorption in severe COVID-19 pneumonia requiring ECMO – the CYCOV study
    Alexander Supady, Freiburg/Germany
  • First clinical experiences in the USA
    Nader Moazami, New York/USA
  • Reduction of hyperinflammation, septic shock and MOF – we can do it better
    Ali Akil, Ibbenbueren/Germany

More Videos

Webinar | EuroELSO 2020 Virtual ECMO Day | June 25, 2020
Webinar | EuroELSO 2020 Virtual ECMO Day | June 25, 2020
Webinar | The trinity of COVID-19: Immunity, Inflammation and Intervention | May 20th 2020
Webinar | The trinity of COVID-19: Immunity, Inflammation and Intervention | May 20th 2020
Webinar | Cytokine adsorption in severely ill COVID-19 patients | April 16th 2020
Webinar | Cytokine adsorption in severely ill COVID-19 patients | April 16th 2020
Webinar | CytoSorb therapy in COVID-19 patients
Webinar | CytoSorb therapy in COVID-19 patients